Showing results (11-20 of 100) with videos related to
Sort By:
Pageof 10
Oncotarget|May 14, 2015
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignanciesNicola Amodio, Marco Rossi, Lavinia Raimondi, et al.Journal of Ovarian Research|February 8, 2013
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?Nicoletta Staropoli, Domenico Ciliberto, Cirino Botta, et al.Blood Advances|January 4, 2018
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patientsCirino Botta, Domenico Ciliberto, Marco Rossi, et al.International Journal of Molecular Sciences|May 13, 2023
B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell LymphomaLeila Mohammadnezhad, Mojtaba Shekarkar Azgomi, Marco Pio La Manna, et al.Cancers|July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic OpportunitiesCirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.Microarrays (Basel, Switzerland)|September 27, 2016
OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical OutcomesGiuseppe Agapito, Cirino Botta, Pietro Hiram Guzzi, et al.Frontiers in Medicine|January 29, 2026
Identification of CD320, SLC44A1 and TNFRSF13B as potential novel therapeutic targets for CAR T-cell therapy in multiple myelomaFrancesca Garofano, Anna Maria Corsale, Marta Biondo, et al.Immunotherapy|December 21, 2016
Immunotherapy of colorectal cancer: new perspectives after a long pathPierpaolo Correale, Cirino Botta, Domenico Ciliberto, et al.Cancer Biology & Therapy|March 25, 2014
Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trialsNicoletta Staropoli, Domenico Ciliberto, Cirino Botta, et al.Journal of Hematology & Oncology|April 24, 2025
Spatial imaging unlocks the potential of charting multiple myeloma and extramedullary diseaseVanessa Desantis, Alessandro Andriano, Tim Düking, et al.Pageof 10